Fluid Challenge Impact in the Portal Vein Pulsatility Depending on the Fluid Responsivness Status
FLUID-REVENGE
2 other identifiers
observational
36
1 country
1
Brief Summary
Portal vein pulsatility index is a marker of venous congestion evaluated by point of care ultrasound. It is associated with acute kidney injury, especially in critically ill patients. It may be considered as a dynamic marker. The investigators hypothesized that portal vein pulsatility index is higher after a fluid challenge only in patient without preload dependence in critically ill patients with cardiovascular insufficiency.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2023
CompletedFirst Posted
Study publicly available on registry
April 25, 2023
CompletedStudy Start
First participant enrolled
July 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 3, 2024
CompletedJune 7, 2024
June 1, 2024
11 months
March 16, 2023
June 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Portal vein pulsatility index variation induced by the fluid challenge (%), defined by: Portal vein pulsatility index before the fluid challenge - portal vein pulsatility index after the fluid challenge.
Portal vein pulsatility index is defined as the (maximal velocity - minimal velocity) / maximal velocity assessed with doppler in portal vein estimated with point of care ultrasound.
One hour
Study Arms (1)
Cohort
Population: Critically ill patient with: * cardio circulatory insufficiency as defined by vasopressor requirement and at least one of the following criteria: arterial lactate \>2mmol/L ; capillary refill time \>3s ; mottling score \>1 ; diuresis \<0,5mL/h for more than 6hours * diameter of inferior vena cava \>20mm Protocol: Administration of a fluid challenge (4mL/kg of Ringer Lactate) over 5 to 10 min. Point of care ultrasound evaluation of portal vein pulsatility index and Vexus criteria before and after the fluid challenge ; fluid challenge induced cardiac index variations estimated by pulse contour analysis
Eligibility Criteria
Adult intensive care patients with both grade 1 or higher venous congestion (VeXus C criteria) and acute circulatory failure.
You may qualify if:
- vasopressor requirement to maintain mean arterial pressure \>65mmHg AND
- at least one of the following criteria:
- arterial lactate \>2mmol/L;
- capillary refill time \>3s;
- mottling score \>1;
- diuresis \<0,5mL/h for more than 6hours.
You may not qualify if:
- Diameter of vena cava \<20mm
- Cirrhosis
- Pregnancy
- Severe acute pulmonary edema
- Phototype 4 or 5
- Patient opposition to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital cardiologique Louis Pradel
Bron, 69500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin RUSTE, MD
Département d'anesthésie-réanimation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2023
First Posted
April 25, 2023
Study Start
July 10, 2023
Primary Completion
June 3, 2024
Study Completion
June 3, 2024
Last Updated
June 7, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share